association of cluster headache and secondary blepharospasm bagheri a, md*; mohammadi m, md; khosravi fard k, md; harooni g, md ophthalmic research center, shahid beheshti university of medical sciences, tehran, iran * corresponding author: [email protected] purpose: to report a case of cluster headache associated with secondary blepharospasm and its management. case report: a 37-year-old ...

Introduction: Blepharospasm is a condition of involuntary spasm the orbicularis oculi muscle which leads to intermittent or complete closure eyelids. Botulinum toxin currently recommended first line treatment for such blepharospasm. This study aims find out outcome injection Type A in Blepharospasm.
 Materials and methods: It was hospital based, prospective, interventional conducted on pat...

BACKGROUND Blepharospasm can be present as an isolated dystonia or in conjunction with other forms of cranial dystonia, causing significant disability. CASE REPORT We report a case of a 69-year-old male with craniocervical dystonia, manifesting primarily as incapacitating blepharospasm refractory to medical treatments. He underwent bilateral globus pallidus (GP) deep brain stimulation (DBS) w...

OBJECTIVE Although the mixed orbicularis oculi muscle lacks the muscle spindles required to induce reflex contraction of its slow-twitch fibers, the mechanoreceptors in Müller's muscle function as extrinsic mechanoreceptors to induce reflex contraction. We hypothesize that strong stretching of these mechanoreceptors increases reflex contraction of the orbicularis oculi slow-twitch muscle fibers...

PURPOSE To evaluate the costs and efficacy of type A botulinum toxin in the treatment of essential blepharospasm and hemifacial spasm. METHODS Pacients with essential blepharospasm and hemifacial spasm had their files analyzed. All patients were treated with type A botulinum toxin (Dysport) between April 2002 and May 2004 at the Oculoplastic Clinics of "Santa Casa de São Paulo". Twenty-seven ...

BACKGROUND The aim was to elucidate clinical trial efficacy, safety, and dosing practices of abobotulinumtoxinA (ABO) treatment in adult patients with blepharospasm and hemifacial spasm. To date, most literature reviews for blepharospasm and hemifacial spasm have examined the effectiveness of all botulinum neurotoxin type A products as a class. However, differences in dosing units and recommend...

BACKGROUND Primary blepharospasm is a focal dystonia characterised by excessive involuntary closure of the eyelids. The pathophysiology of primary blepharospasm is unresolved. AIM To pinpoint grey-matter changes that are associated with primary blepharospasm. METHODS 16 right-handed patients with primary blepharospasm (mean age 67.4 (SD 4.3) years; 12 women) were compared with 16 healthy vo...

OBJECTIVES Administration of botulinum neurotoxin A (BONT/A) is a common and effective treatment of blepharospasm. There is, however, no information regarding the emotional and social well-being of patients with blepharospasm and patient acceptance of BONT/A therapy. The purpose of this study was to investigate aspects of quality of life of patients with blepharospasm and level of patient satis...

OBJECTIVE It was to analyze clinical aspects of patients with blepharospasm, including outcomes of botulinum toxin treatment. Additionally, clinical characteristics of isolated blepharospasm were compared to those of blepharospasm plus other movement disorders. METHODS Clinical data recorded during 17 years were reviewed. The variables included age, gender, age of onset, past medical history,...